The effects of L-citrulline supplementation on cerebrovascular function during sprint interval training in taekwondo athletes
Question
Does short-term L-citrulline supplementation improve cerebrovascular recovery after sprint interval cycling in trained male taekwondo athletes?
Summary
In a double-blind randomized crossover study, 20 male taekwondo athletes took L-citrulline or placebo for 5 days before a sprint interval cycling session. L-citrulline improved the breath-holding index recovery measure after exercise but did not significantly change sprint power or pulse index.
Methodology
- Male taekwondo athletes with provincial-or-higher competition experience
- 20 participants.
- Cycle ergometer.
- Work intervals: 30 seconds maximal sprint.
- Recovery: 3 minutes active recovery without resistance.
- Intensity: Maximal pedaling against 0.075 kp/kg body weight.
- 5-minute warm-up plus four sprints and recoveries.
- Single test session per supplementation phase.
- 5-day supplementation phase before test.
- Double-blind randomized crossover supplementation trial
- Breath-holding index, Pulse index, and Average power were tracked.
Outcomes
BHI recovery
L-citrulline improved delta BHI versus placebo after SIT.
Delta BHI 0.07 +/- 0.22 with L-citrulline vs -0.18 +/- 0.46 placebo; F=5.09, p=0.037, partial eta squared=0.22.
Average power
Average sprint power was not significantly different between conditions.
F=1.27, p=0.275, partial eta squared=0.07.
Pulse index
Pulse index change did not significantly differ between conditions.
F=0.19, p=0.669, partial eta squared=0.01.
Insights
- This paper supports a narrow recovery-marker claim, not a performance claim.
- The sprint protocol is reproducible but equipment-based and athlete-specific.
- Consumer supplement messaging should note the small male-athlete crossover design.
Limitations
- Small sample size.
- Male taekwondo athletes only.
- Short-term supplement and acute exercise design.
- Surrogate cerebrovascular outcomes.
- Diet, sleep, and stress were not fully controlled.
Safety
- No adverse-event results were reported in the the paper.
- Participants were medically screened and supplement allergies were exclusionary.